News
Tracking Mario Gabelli’s Gabelli Funds 13F Portfolio – Q2 2024 Update (OTCMKTS:GAMI)
This article is part of a series that provides an ongoing analysis of the changes made to Gabelli Funds’ 13F…
Chemed Stock Remains A Buy On Long-Term Economics (NYSE:CHE)
Investment update Following my last publication on Chemed Corporation (NYSE:CHE) the stock is flat, and I am reiterating my buy…
Amicus Therapeutics Stock: A Compelling Investment In The Rare Disease Biotech Sector
Amicus Therapeutics, Inc. (NASDAQ:FOLD) focuses on rare and orphan diseases, particularly Fabry and Pompe. The company’s portfolio includes Galafold and…
Vistra Stock: Not As Expensive As It Looks, Full Steam Ahead (NYSE:VST)
Over the next 6 years, data centers are expected to go from consuming 3% of the United States' power supply…
Peyto Stock Q2: Making Money In Natural Gas (OTCMKTS:PEYUF)
(Note: Peyto is a Canadian company that reports using Canadian Dollars unless otherwise noted.) Peyto (OTCPK:PEYUF) is a natural gas…
Applied Materials, Inc. (AMAT) Q3 2024 Earnings Call Transcript
Applied Materials, Inc. (NASDAQ:AMAT) Q3 2024 Earnings Conference Call August 15, 2024 4:30 PM ET Company Participants Michael Sullivan -…
Blade: Margins Remain An Issue (NASDAQ:BLDE)
Blade Air Mobility, Inc. (NASDAQ:BLDE) reported solid results in Q2, achieving its first positive adjusted EBITDA quarter as a public…
Ouster Q2: Why The Selloff Doesn’t Add Up And Why $23 Per Share Remains A Target (OUST)
Ouster, Inc. (NYSE:OUST) has delivered record results for yet another record quarter. The company stands out among smoldering ruins of…